CRISPR:Article Title: CRISPR activation screen identifies BCL-2 proteins and B3GNT2 as drivers of cancer resistance to T cell-mediated cytotoxicity
Article Snippet: 1 Department of Biological Engineering, MIT, Cambridge, MA 02139, USA 2 Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA 3 Department of Brain and Cognitive Science, MIT, Cambridge, MA 02139, USA 4 McGovern Institute for Brain Research at MIT, Cambridge, MA 02139, USA 5 Howard Hughes Medical Institute, MIT, Cambridge, MA 02139, USA 6 Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA 7 Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA 8 Present address: Whitehead Institute, Cambridge, MA 02142, USA .. Supplementary Information CRISPR activation screen identifies BCL-2 proteins and B3GNT2 as drivers of cancer resistance to T cell-mediated cytotoxicity Julia Joung1,2,3,4,5,8,†, Paul C. Kirchgatterer1,2,3,4,5, Ankita Singh1,2,3,4,5, Jang H. Cho1,2,3,4,5, Suchita P. Nety1,2,3,4,5, Rebecca C. Larson6,7, Rhiannon K. Macrae1,2,3,4,5, Rebecca Deasy2, Yuen-Yi Tseng2, Marcela V. Maus6,7, and Feng Zhang1,2,3,4,5,† 1 Department of Biological Engineering, MIT, Cambridge, MA 02139, USA 2 Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA 3 Department of Brain and Cognitive Science, MIT, Cambridge, MA 02139, USA 4 McGovern Institute for Brain Research at MIT, Cambridge, MA 02139, USA 5 Howard Hughes Medical Institute, MIT, Cambridge, MA 02139, USA 6 Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA 7 Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA 8 Present address: Whitehead Institute, Cambridge, MA 02142, USA † Correspondence should be addressed to julia@joung.science (J.J.) and zhang@broadinstitute.org (F.Z.). ..
Article Title: Identification of regulators of poly-ADP-ribose polymerase (PARP) inhibitor response through complementary CRISPR knockout and activation screens
Article Snippet: .. For the CRISPR activation screen, HeLa BRCA2-knockout cells were infected with dCas9 (Addgene, 61425-LV) and selected with blasticidin (3 μg/ml). dCas9-expressing cells were then transduced with the Calabrese Human CRISPR Activation Pooled Library (Set A, Addgene, 92379-LV) using enough cells to obtain a library coverage of 500 cells per sgRNA at an MOI of 0.4. ..
Activation Assay:Article Title: CRISPR activation screen identifies BCL-2 proteins and B3GNT2 as drivers of cancer resistance to T cell-mediated cytotoxicity
Article Snippet: 1 Department of Biological Engineering, MIT, Cambridge, MA 02139, USA 2 Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA 3 Department of Brain and Cognitive Science, MIT, Cambridge, MA 02139, USA 4 McGovern Institute for Brain Research at MIT, Cambridge, MA 02139, USA 5 Howard Hughes Medical Institute, MIT, Cambridge, MA 02139, USA 6 Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA 7 Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA 8 Present address: Whitehead Institute, Cambridge, MA 02142, USA .. Supplementary Information CRISPR activation screen identifies BCL-2 proteins and B3GNT2 as drivers of cancer resistance to T cell-mediated cytotoxicity Julia Joung1,2,3,4,5,8,†, Paul C. Kirchgatterer1,2,3,4,5, Ankita Singh1,2,3,4,5, Jang H. Cho1,2,3,4,5, Suchita P. Nety1,2,3,4,5, Rebecca C. Larson6,7, Rhiannon K. Macrae1,2,3,4,5, Rebecca Deasy2, Yuen-Yi Tseng2, Marcela V. Maus6,7, and Feng Zhang1,2,3,4,5,† 1 Department of Biological Engineering, MIT, Cambridge, MA 02139, USA 2 Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA 3 Department of Brain and Cognitive Science, MIT, Cambridge, MA 02139, USA 4 McGovern Institute for Brain Research at MIT, Cambridge, MA 02139, USA 5 Howard Hughes Medical Institute, MIT, Cambridge, MA 02139, USA 6 Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA 7 Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA 8 Present address: Whitehead Institute, Cambridge, MA 02142, USA † Correspondence should be addressed to julia@joung.science (J.J.) and zhang@broadinstitute.org (F.Z.). ..
Article Title: Identification of regulators of poly-ADP-ribose polymerase (PARP) inhibitor response through complementary CRISPR knockout and activation screens
Article Snippet: .. For the CRISPR activation screen, HeLa BRCA2-knockout cells were infected with dCas9 (Addgene, 61425-LV) and selected with blasticidin (3 μg/ml). dCas9-expressing cells were then transduced with the Calabrese Human CRISPR Activation Pooled Library (Set A, Addgene, 92379-LV) using enough cells to obtain a library coverage of 500 cells per sgRNA at an MOI of 0.4. ..
Infection:Article Title: Identification of regulators of poly-ADP-ribose polymerase (PARP) inhibitor response through complementary CRISPR knockout and activation screens
Article Snippet: .. For the CRISPR activation screen, HeLa BRCA2-knockout cells were infected with dCas9 (Addgene, 61425-LV) and selected with blasticidin (3 μg/ml). dCas9-expressing cells were then transduced with the Calabrese Human CRISPR Activation Pooled Library (Set A, Addgene, 92379-LV) using enough cells to obtain a library coverage of 500 cells per sgRNA at an MOI of 0.4. ..
Transduction:Article Title: Identification of regulators of poly-ADP-ribose polymerase (PARP) inhibitor response through complementary CRISPR knockout and activation screens
Article Snippet: .. For the CRISPR activation screen, HeLa BRCA2-knockout cells were infected with dCas9 (Addgene, 61425-LV) and selected with blasticidin (3 μg/ml). dCas9-expressing cells were then transduced with the Calabrese Human CRISPR Activation Pooled Library (Set A, Addgene, 92379-LV) using enough cells to obtain a library coverage of 500 cells per sgRNA at an MOI of 0.4. ..
Genome Wide:Article Title: Genome-wide CRISPR activation screen identifies JADE3 as an antiviral activator of NF-kB
Article Snippet: 1 Departments of Immunology and Microbiology, University of Texas Southwestern Medical Center, Dallas, TX, USA 2 Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA 3 Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA 4 Department of Molecular Genetics and Microbiology, Duke University School of Medicine, Durham, NC, USA 5 Departments of Laboratory Medicine and Immunobiology, Yale School of Medicine, New Haven, CT, USA # Correspondence to: Robert.Orchard@UTSouthwestern.edu .. SUPPLEMENTAL INFORMATION APPENDIX Genome-wide CRISPR activation screen identifies JADE3 as an antiviral activator of NF-kB Moiz Munir1, Aaron Embry1, John G. Doench2, Peter Palese3, Nicholas S. Heaton4, Craig B. Wilen5, Robert C. Orchard1# 1 Departments of Immunology and Microbiology, University of Texas Southwestern Medical Center, Dallas, TX, USA 2 Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA 3 Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, ..
|